SEK 37.0
(-1.99%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 29.6 Million DKK | -16.88% |
2022 | 35.62 Million DKK | -33.18% |
2021 | 53.3 Million DKK | 218.41% |
2020 | 16.74 Million DKK | 219.63% |
2019 | 5.23 Million DKK | 6859.6% |
2018 | 75.26 Thousand DKK | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 20.61 Million DKK | -30.38% |
2024 Q2 | 40.81 Million DKK | 97.97% |
2023 Q2 | 19.58 Million DKK | -30.09% |
2023 Q1 | 28.01 Million DKK | -21.34% |
2023 FY | 29.6 Million DKK | -16.88% |
2023 Q4 | 29.6 Million DKK | 32.44% |
2023 Q3 | 22.35 Million DKK | 14.14% |
2022 Q4 | 35.62 Million DKK | -22.86% |
2022 FY | 35.62 Million DKK | -33.18% |
2022 Q2 | 52.35 Million DKK | -9.93% |
2022 Q3 | 46.17 Million DKK | -11.8% |
2022 Q1 | 58.12 Million DKK | 9.03% |
2021 Q1 | 10.37 Million DKK | -38.05% |
2021 FY | 53.3 Million DKK | 218.41% |
2021 Q3 | 55.39 Million DKK | -5.08% |
2021 Q4 | 53.3 Million DKK | -3.76% |
2021 Q2 | 58.36 Million DKK | 462.72% |
2020 Q1 | 14.63 Million DKK | 179.31% |
2020 FY | 16.74 Million DKK | 219.63% |
2020 Q4 | 16.74 Million DKK | -23.3% |
2020 Q3 | 21.82 Million DKK | -14.97% |
2020 Q2 | 25.67 Million DKK | 75.46% |
2019 Q3 | 11.79 Million DKK | -5.02% |
2019 Q4 | 5.23 Million DKK | -55.61% |
2019 Q2 | 12.42 Million DKK | 137.56% |
2019 Q1 | 5.22 Million DKK | 6847.64% |
2019 FY | 5.23 Million DKK | 6859.6% |
2018 FY | 75.26 Thousand DKK | 0.0% |
2018 Q4 | 75.26 Thousand DKK | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
AddLife AB (publ) | 12.74 Billion SEK | 99.768% |
Biotage AB (publ) | 4.93 Billion SEK | 99.4% |
Bonesupport Holding AB (publ) | 688.81 Million SEK | 95.701% |
Doxa AB (publ) | 3.75 Billion SEK | 99.211% |
Elekta AB (publ) | 31.41 Billion SEK | 99.906% |
iZafe Group AB (publ) | 34.61 Million SEK | 14.459% |
Ortivus AB (publ) | 72.7 Million SEK | 59.276% |
Ortivus AB (publ) | 72.7 Million SEK | 59.276% |
Q-linea AB (publ) | 231.97 Million SEK | 87.236% |
S2Medical AB (publ) | 21.4 Million SEK | -38.312% |
Synsam AB (publ) | 8.03 Billion SEK | 99.632% |